| 1 |
33503040 | Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia. | 2021 |
1 |
| 2 |
34899282 | Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients. | 2021 |
1 |
| 3 |
32727562 | Identification and targeting of selective vulnerability rendered by tamoxifen resistance. | 2020 Jul 29 |
4 |
| 4 |
30120701 | Genetic polymorphisms of 3'-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy. | 2018 Nov |
1 |
| 5 |
27221864 | Effects of SULT1A1 Copy Number Variation on Estrogen Concentration and Tamoxifen-Associated Adverse Drug Reactions in Premenopausal Thai Breast Cancer Patients: A Preliminary Study. | 2016 |
1 |
| 6 |
25819444 | The effects of endoxifen and other major metabolites of tamoxifen on the sulfation of estradiol catalyzed by human cytosolic sulfotransferases hSULT1E1 and hSULT1A1*1. | 2015 Jun |
1 |
| 7 |
23922954 | Relationship between genotypes Sult1a2 and Cyp2d6 and tamoxifen metabolism in breast cancer patients. | 2013 |
1 |
| 8 |
22708928 | SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer? | 2012 Jun 18 |
6 |
| 9 |
20309015 | Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial. | 2011 Apr |
1 |
| 10 |
21961651 | SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen. | 2011 Nov |
2 |
| 11 |
20628863 | Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues. | 2010 Nov |
1 |
| 12 |
21537383 | Expression of sulfotransferase isoform 1A1 (SULT1A1) in breast cancer cells significantly increases 4-hydroxytamoxifen-induced apoptosis. | 2010 Jan 30 |
5 |
| 13 |
17947222 | Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. | 2008 Jan |
7 |
| 14 |
19088019 | Pharmacogenetics in breast cancer therapy. | 2008 Dec 15 |
2 |
| 15 |
17244352 | Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer. | 2007 |
1 |
| 16 |
16317586 | Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy. | 2006 Jan |
1 |
| 17 |
16517757 | Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. | 2006 Jun |
1 |
| 18 |
15987423 | Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients. | 2005 |
3 |
| 19 |
12419790 | Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. | 2002 Nov 6 |
5 |